Search





Search





Markets
/
Stocks
/
tlsi
/

TriSalus Life Sciences Inc

TLSI

Add to Watchlist

4.540USD

-0.020-0.44%

Close 07-31 16:00（ET）Quotes delayed by 15 min

278.83MMarket Cap

LossP/E TTM

TriSalus Life Sciences Inc

4.540

-0.020-0.44%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

TLSI Cash Flow Statement

You can access the annual and quarterly cash flow statements of TriSalus Life Sciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-44.03%-6.48M

56.47%-2.48M

65.81%-3.71M

45.46%-7.32M

58.60%-4.50M

37.81%-5.71M

49.93%-10.85M

-45.43%-13.42M

-3.47%-10.87M

-10.43%-9.18M

-307.41%-21.66M

-14.01%-9.23M

0.83%-10.50M

-85.24%-8.31M

---5.32M

---8.10M

---10.59M

---4.49M

Net income from continuing operations

114.83%1.54M

3.51%-9.75M

-353.10%-10.81M

-91.32%-8.29M

21.51%-10.38M

71.64%-10.11M

-61.00%-2.39M

69.00%-4.33M

-59.88%-13.22M

-58.10%-35.64M

81.69%-1.48M

-61.01%-13.97M

-5.02%-8.27M

-223.83%-22.54M

---8.09M

---8.68M

---7.87M

---6.96M

Operating gains losses

-21.51%135.00K

-34.72%126.00K

-3.55%163.00K

-14.95%165.00K

-8.51%172.00K

-0.52%193.00K

8.33%169.00K

29.33%194.00K

2.17%188.00K

--194.00K

-25.36%156.00K

2400.00%150.00K

-33.09%184.00K

----

--209.00K

--6.00K

--275.00K

--157.00K

Other non-cash items

-27.67%379.00K

-34.69%337.00K

662.93%653.00K

253.01%127.00K

589.47%524.00K

616.67%516.00K

70.26%-116.00K

-109.42%-83.00K

108.74%76.00K

178.26%72.00K

-139.00%-390.00K

--881.00K

---870.00K

-105.28%-92.00K

--1.00M

----

--0.00

--1.74M

Change in working capital

-81.49%296.00K

-213.49%-530.00K

175.71%2.39M

78.24%-1.39M

431.06%1.60M

-88.03%467.00K

31.97%-3.15M

-427.52%-6.38M

29.28%-483.00K

5.74%3.90M

-435.14%-4.63M

637.88%1.95M

77.52%-683.00K

122.35%3.69M

--1.38M

--264.00K

---3.04M

--1.66M

-Change in receivables

452.73%1.29M

-340.72%-1.59M

341.26%497.00K

59.44%-174.00K

49.38%-366.00K

28.09%-361.00K

78.09%-206.00K

14.54%-429.00K

-1965.71%-723.00K

-168.21%-502.00K

-16.92%-940.00K

-147.29%-502.00K

-149.30%-35.00K

1250.00%736.00K

---804.00K

---203.00K

--71.00K

---64.00K

-Change in inventory

-514.91%-701.00K

514.58%199.00K

195.50%531.00K

166.85%355.00K

69.02%-114.00K

94.75%-48.00K

-419.63%-556.00K

-366.83%-531.00K

-47.20%-368.00K

-394.59%-915.00K

-275.41%-107.00K

415.87%199.00K

-3225.00%-250.00K

65.87%-185.00K

--61.00K

---63.00K

--8.00K

---542.00K

-Change in prepaid expenses

-182.78%-423.00K

-68.78%192.00K

56.71%-129.00K

108.93%266.00K

-46.49%511.00K

6933.33%615.00K

-122.80%-298.00K

-1020.30%-2.98M

374.43%955.00K

99.65%-9.00K

-11.15%1.31M

81.92%-266.00K

---348.00K

---2.59M

--1.47M

---1.47M

----

-Change in payables and accrued expense

-90.15%160.00K

129.90%692.00K

174.77%1.51M

23.14%-1.81M

632.46%1.62M

-94.43%301.00K

56.30%-2.02M

-211.29%-2.35M

-1486.36%-305.00K

22.88%5.41M

-336.31%-4.63M

4709.09%2.12M

101.90%22.00K

146.00%4.40M

--1.96M

--44.00K

---1.16M

--1.79M

-Change in other current assets

----

-94.92%72.00K

95.48%-59.00K

-79.51%401.00K

----

197.27%1.42M

---1.31M

--1.96M

---1.96M

--477.00K

-Change in other current liabilities

----

--5.00K

----

-100.00%0.00

--0.00

--43.00K

--0.00

----

--0.00

----

Cash from non-recurring investing activities

Cash from operating activities

-44.03%-6.48M

56.47%-2.48M

65.81%-3.71M

45.46%-7.32M

58.60%-4.50M

37.81%-5.71M

49.93%-10.85M

-45.43%-13.42M

-3.47%-10.87M

-10.43%-9.18M

-307.41%-21.66M

-14.01%-9.23M

0.83%-10.50M

-85.24%-8.31M

---5.32M

---8.10M

---10.59M

---4.49M

Investing cash flow

Net cash from continuing investing activities

-80.25%141.00K

-18.00%41.00K

4.14%176.00K

-255.00%-93.00K

981.82%714.00K

-86.56%50.00K

-5.06%169.00K

93.55%60.00K

842.86%66.00K

82.35%372.00K

249.02%178.00K

-76.15%31.00K

-97.41%7.00K

-61.22%204.00K

--51.00K

--130.00K

--270.00K

--526.00K

Capital expenditures

-81.30%141.00K

-18.00%41.00K

27.81%216.00K

----

1042.42%754.00K

-86.56%50.00K

-5.06%169.00K

93.55%60.00K

842.86%66.00K

82.35%372.00K

249.02%178.00K

-76.15%31.00K

-97.41%7.00K

-61.22%204.00K

--51.00K

--130.00K

--270.00K

--526.00K

Net cash flow from disposal of fixed assets

-80.25%141.00K

-18.00%41.00K

4.14%176.00K

-255.00%-93.00K

981.82%714.00K

-86.56%50.00K

-5.06%169.00K

93.55%60.00K

842.86%66.00K

82.35%372.00K

249.02%178.00K

-76.15%31.00K

-97.41%7.00K

-61.22%204.00K

--51.00K

--130.00K

--270.00K

--526.00K

Net cash flow from investment products

----

--0.00

----

-100.00%0.00

100.00%0.00

10.36%-934.00K

-99.07%1.00K

48.06%-67.00K

-172.00%-68.00K

---1.04M

--108.00K

---129.00K

---25.00K

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

80.25%-141.00K

18.00%-41.00K

-4.14%-176.00K

255.00%93.00K

-981.82%-714.00K

86.56%-50.00K

84.80%-169.00K

-100.00%-60.00K

10.81%-66.00K

-36.76%-372.00K

-1.74%-1.11M

-36.36%-30.00K

81.45%-74.00K

50.64%-272.00K

---1.09M

---22.00K

---399.00K

---551.00K

Financing cash flow

Cash flow from continuous financing activities

337.50%42.38M

-90.75%277.00K

-98.59%82.00K

-20.30%20.72M

209.92%9.69M

6862.79%2.99M

-85.53%5.82M

305.95%25.99M

-60.58%3.13M

-99.27%43.00K

908.34%40.25M

82.84%6.40M

13116.67%7.93M

43.92%5.91M

--3.99M

--3.50M

--60.00K

--4.11M

Net cash flow from debt Issuance/repayment

-100.09%-9.00K

84.21%-3.00K

72.73%-6.00K

-100.00%-1.00K

45231.82%9.93M

13.64%-19.00K

0.00%-22.00K

119047.62%24.98M

0.00%-22.00K

82.68%-22.00K

-2100.00%-22.00K

-950.00%-21.00K

-2100.00%-22.00K

71.96%-127.00K

---1.00K

---2.00K

---1.00K

---453.00K

Net cash flow from common stock issuance/repurchase

--42.63M

-86.31%404.00K

-100.00%0.00

516.63%22.21M

-100.00%0.00

--2.95M

--5.84M

--3.60M

--3.14M

--0.00

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--5.00K

71.53%6.00M

--3.18M

126.91%10.00M

--0.00

--3.50M

--0.00

--4.41M

Proceeds from stock option exercised by employees

-88.53%32.00K

40.32%87.00K

4300.00%88.00K

1020.00%56.00K

3885.71%279.00K

-27.06%62.00K

-92.86%2.00K

-68.75%5.00K

-86.00%7.00K

304.76%85.00K

300.00%28.00K

220.00%16.00K

-18.03%50.00K

-38.24%21.00K

--7.00K

--5.00K

--61.00K

--34.00K

Proceeds from issuance of warrants

----

---20.00K

----

Net cash flow from other financing activities

49.42%-263.00K

---211.00K

--0.00

40.26%-1.55M

---520.00K

--0.00

-100.00%0.00

-738.67%-2.59M

-100.00%0.00

100.00%0.00

909.58%40.24M

--406.00K

--4.72M

-3506.84%-3.99M

--3.99M

--0.00

--117.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

337.50%42.38M

-90.75%277.00K

-98.59%82.00K

-20.30%20.72M

209.92%9.69M

6862.79%2.99M

-85.53%5.82M

305.95%25.99M

-60.58%3.13M

-99.27%43.00K

908.34%40.25M

82.84%6.40M

13116.67%7.93M

43.92%5.91M

--3.99M

--3.50M

--60.00K

--4.11M

Net cash flow

Beginning cash balance

134.24%20.79M

97.95%23.04M

59.47%26.84M

209.03%13.35M

-26.82%8.88M

-46.20%11.64M

305.18%16.83M

-38.37%4.32M

25.49%12.13M

75.34%21.63M

-71.85%4.15M

-63.81%7.01M

-68.11%9.66M

-60.50%12.34M

--14.76M

--19.37M

--30.30M

--31.23M

Current period cash flow changes

699.20%35.76M

18.64%-2.25M

26.77%-3.80M

7.83%13.49M

157.32%4.47M

70.93%-2.76M

-129.71%-5.19M

538.06%12.51M

-194.94%-7.81M

-255.50%-9.51M

822.87%17.48M

38.11%-2.86M

75.78%-2.65M

-186.91%-2.67M

---2.42M

---4.62M

---10.93M

---932.00K

Ending cash balance

323.62%56.55M

134.24%20.79M

97.95%23.04M

59.47%26.84M

209.03%13.35M

-26.82%8.88M

-46.20%11.64M

305.18%16.83M

-38.44%4.32M

25.49%12.13M

75.34%21.63M

-71.85%4.15M

-63.78%7.02M

-68.11%9.66M

--12.34M

--14.76M

--19.37M

--30.30M

Free cash flow

-26.04%-6.62M

56.14%-2.52M

64.37%-3.92M

45.71%-7.32M

51.95%-5.25M

39.71%-5.76M

49.56%-11.02M

-45.59%-13.48M

-4.02%-10.93M

-12.16%-9.55M

-306.86%-21.84M

-12.58%-9.26M

3.23%-10.51M

-69.87%-8.51M

---5.37M

---8.22M

---10.86M

---5.01M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did TriSalus Life Sciences Inc Generate?



TriSalus Life Sciences Inc generated -18.01M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did TriSalus Life Sciences Inc's Operating Cash Flow Change Year Over Year?



TriSalus Life Sciences Inc's operating cash flow increased by 55.90% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does TriSalus Life Sciences Inc Spend on Capital Expenditures?



TriSalus Life Sciences Inc spent 918.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has TriSalus Life Sciences Inc's Financing Cash Flow Changed?



TriSalus Life Sciences Inc used 30.76M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TLSI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was TriSalus Life Sciences Inc’s free cash flow in the latest quarter?



Free cash flow was -18.93M reflecting a 54.04% change from the previous year.